|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1999-2-25
|
|
pubmed:abstractText |
This randomised trial was designed to investigate the activity and toxicity of continuous infusion etoposide phosphate (EP), targeting a plasma etoposide concentration of either 3 micrograms/ml for five days (5d) or 1 microgram/ml for 15 days (15d), in previously untreated SCLC patients with extensive disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1205-11
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9862051-Adult,
pubmed-meshheading:9862051-Aged,
pubmed-meshheading:9862051-Antineoplastic Agents,
pubmed-meshheading:9862051-Carcinoma, Small Cell,
pubmed-meshheading:9862051-Drug Administration Schedule,
pubmed-meshheading:9862051-Etoposide,
pubmed-meshheading:9862051-Female,
pubmed-meshheading:9862051-Humans,
pubmed-meshheading:9862051-Lung Neoplasms,
pubmed-meshheading:9862051-Male,
pubmed-meshheading:9862051-Middle Aged,
pubmed-meshheading:9862051-Organophosphorus Compounds
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
A randomised, concentration-controlled, comparison of standard (5-day) vs. prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer.
|
|
pubmed:affiliation |
ICRF Department of Medical Oncology, St. Bartholomew's Hospital, West Smithfield, London, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
